Reminder of Dr M’s comments at the 5:31 mark of the 10/4/19 Cantor Fitzgerald investor presentation: “so we now are about to find treatments for these indications, which we call neurodevelopmental neurodegenerative diseases” (speaking of AD PDD RS). ... could be a language translation but it sounded quite confident IMO
And at 5:47 of presentation: “And pleased to share that we are expecting data on the first study soon, we have already the first 6 patients’ data which we will see in a minute” (in regard to Rett studies)
I’m inclined to believe that the 21 patients (over 18 years old) in the US RS trial are already dosing and readouts expected soon, otherwise I’m not sure why he’d say what he said at the 5:47 mark. Why say that if you were still looking for the first 21 patients? Would seem odd if so.
Just random thoughts on a slow Friday afternoon.